Abstract
This study aimed to assess the effect of autologous bone marrow on metacarpal and metatarsal fractures in goats presented to the indoor surgery clinic at the University of Veterinary and Animal Sciences (UVAS) in Lahore, Pakistan. A total of 20 female Beetal goats weighing 20-22.5 kg and aged 8-12 months were allocated into equal groups of five animals each: G1, G2, G3, and G4. Animals in G1 were fixed with a linear external skeletal fixator, and animals in G3 were fixed with a circular fixator and treated with multiple aspirates from the bone marrow, while animals in G2 were fixed the same way as G1, and animals in G4 were fixed the same way as G3 and treated with normal saline on days 0, 14, and 28. The radiographic union scale (RUS) and weight-bearing score (WBS) were used to evaluate the post-treatment rate of repair, and sero-biochemical changes were observed on days 0, 7, 14, 28, and 45. The results showed a significant difference (P<0.05) in bone healing among groups treated with bone marrow aspirates (BMA) and groups treated with normal saline. RUS and WBS scoring in G1 and G3 animals were significantly higher (P<0.05) than in G2 and G4 animals on days 7, 14, and 28. Moreover, animals in G1 and G3 had significantly (P<0.05) greater levels of alkaline phosphatase, total hydroxyproline, and free hydroxyproline than animals in G2 and G4, respectively. In conclusion, the application of BMA at the site of fracture aids in the healing of fractured metacarpal and metatarsal bones aligned with external (linear and circular) fixators in goats.
Main Subjects
Highlights
Full Text
Introduction
Ethical Approve
This study and all techniques were conducted following the rules and regulations of the Ethical Review Committee (Ethical Approval No. DR/27; Dated: 01/10/2019) at the Department of Veterinary Surgery and Pet Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Experimental design and treatments
A total of 20 clinical cases of long-bone metacarpal and metatarsal fractures in Beetal goats were selected for the study. These cases were presented at the University of Veterinary and Animal Sciences (UVAS), Lahore. All the selected animals were female, with an average body weight of 20-22.5 kg and an age of 8-12 months. All animals were brought in on the same day of metacarpal and metatarsal fracture occurrence. The animals with metatarsal and metacarpal fractures were divided into 4 groups, with 5 animals in each group. The first treatment group had fracture fixation using an external linear fixator, and BMA was injected at the site of the fracture line. The second treatment group had fracture fixation using an external linear fixator, and normal saline (NS) was injected at the site of the fracture. In the third treatment group, fracture fixation was done using an external circular fixator, and BMA was inserted at the fracture line. In the fourth treatment group, fracture fixation was done using an external circular fixator, and NS was injected at the fracture line. All the techniques used in this study were conducted under the rules and regulations of the Ethical Review Committee at the Department of Veterinary Surgery and Pet Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Bone marrow aspirate
Animals were placed in lateral recumbency with the donor limb placed upward. The humerus was brought forward cranially, and the elbow was rotated medially. A notch was made between the greater tubercle and the head of the humerus. Using a sternal needle, a puncture was made by slowly twisting the needle clockwise and anticlockwise. The needle was fitted with a 10 mL syringe and inserted into the marrow. After the aspiration of 3 mL of bone marrow, the bone marrow aspirate was centrifuged at 3200 rpm for 15 minutes. The BMA was then injected into the fracture sites and subcutaneously on the 14th and 28th days post-surgery (15).
Preoperative preparation and sedation
Animals selected for surgery fasted for 18-20 hours before surgery. The surgical site was prepared aseptically by clipping, shaving, and scrubbing with a 5% povidone-iodine antiseptic solution, and isopropyl alcohol was used as a degreasing agent. In all treatment groups, animals were sedated with diazepam (Domosedan injection, Orion Corporation, Finland) at a dosage of 0.25 mg per kg of body weight. After sedation, induction was performed using a combination of propofol and ketamine (Fresofol 1% injection, Fresenius Kabi, Austria). Anesthesia was maintained with a constant rate of infusion using a volumetric syringe-driving pump with the combination of diazepam at a rate of 0.02 mg/kg per hour, ketamine at a rate of 0.04 mg/kg per minute, and propofol at a rate of 0.016 mg/kg per minute.
Fracture repair
A close surgical reduction of the fracture was performed in all cases. External skeletal fixation was utilized as the treatment method for metacarpal or metatarsal fractures. For transverse fractures, a linear external skeletal fixator was employed, while a circular external skeletal fixator was used for comminuted fractures in the selected animals. In group G1, a linear external skeletal fixator was applied using a closed approach in all cases (Figure 1). External manipulation of the fracture was performed to align and oppose the bone, and autologous BMA was injected at the site of the fracture. An orthopedic drill (less than 300 rpm) was used to percutaneously drill the pins into each bone. Two pins of 3 mm were inserted in the proximal and distal fragments of the fractured bone, which were then connected using two connecting bars of 3.5 mm on both sides. The bars were secured with stainless steel clamps. The pins were first inserted at the upper and most distal parts of the bone. The clamps were then connected to the connecting bars, and fracture stability was ensured by tightening the clamps and verifying that the fractured fragments were correctly aligned and opposed. The same surgical procedure as described above was performed in group G2, but with the inoculation of NS instead of BMA at the fracture site.
In group G3, following fracture reduction, one ring of a fixator was introduced at the proximal fragment of the fractured bone, and one ring was introduced at the distal portion (Figure 1). All the rings were made of aluminum and had a diameter of 10 cm. Kirschner pins of 2 mm in diameter were used in all cases, with each ring being fixed with two pins. A 4 mm skin incision was made for the placement of pins using forceps. A blunt dissection of the soft tissue was performed, and a drilling sleeve was used to protect the neurovascular and tendinous structures. Trans-fixation bits were placed around 2 cm distal to the joint associated with the fracture. The boundaries between the pin and skin were washed with a 0.5% to 20% solution of chlorhexidine gluconate, and a gauze soaked with the solution was applied between the skin, fixator, and pin tracts. The dressings were replaced after 24 hours. The same surgical procedure as described for group G3 was performed in group G4, but with NS instead of BMA at the fracture site.
Figure 1: Clinical photograph (a) and lateral radiograph of complete metacarpal fracture in goat; Immediate postoperative lateral radiographs of metacarpal bone; (b) linear skeletal fixator; (c) Linear skeletal fixator on day 0; (d) radiographs for metacarpal bone on day 14, postoperative radiograph for linear fixator + bone marrow; (e) radiographs for metacarpal bone on day 45, postoperative radiograph for linear fixator + bone marrow; (f) circular skeletal fixator; (g) circular skeletal fixator at day 0; (h) radiographs for metacarpal bone on day 14), postoperative radiograph for circular fixator + bone marrow; (i) radiographs for metacarpal bone on day 45, postoperative radiograph for circular fixator + bone marrow
Blood sampling and biochemical evaluation
Blood samples were collected from the jugular vein of goats, approximately 5 mL on day 0 before surgery and thereafter on days 7, 14, 28, and 45 post-surgeries. The blood was collected in sodium citrate vacutainer tubes to prevent coagulation and then transferred to the Diagnostic Laboratory at the University of Veterinary and Animal Sciences in Lahore. The tubes were centrifuged at 3000 rpm for 15 minutes at 4°C using a temperature-controlled centrifuge machine (HARRIER 18/80). The serum was separated and stored at -20°C for further procedures. Samples for the analysis of calcium (Ca), phosphorus (P), alkaline phosphatase (ALKP), free hydroxyproline (FHP), and total hydroxyproline (THP) were stored at -20°C until further analyses. Samples for FHP and THP were analyzed with an automatic analyzer (Biosystems S.A. Costa Brava, Barcelona, Spain), while samples for Ca (MTD Diagnostics, IVD, Italy), P (Spectrum, SAE, Cairo, Egypt), and ALKP (Sigma Aldrich® St. Louis, Missouri, USA) were analyzed using serum diagnostic kits.
Clinical evaluating parameters
The statistical analyses were conducted using IBM SPSS version 20 (IBM Corp., Armonk, NY, USA). Quantitative data were summarized using mean±SD or median and range, while qualitative data were organized using frequencies and percentages. The mean differences of continuous variables between the groups (G1, G2, G3, and G4) were compared using analysis of variance (ANOVA), while the median differences were compared using the Mann-Whitney U test. A p-value > 0.05 indicated no significant difference, while a p-value < 0.05 indicated a significant difference.
Results
Weight-bearing Scoring
The WBS was observed to be the same among the groups at day 0, while at days 7 and 14, there was a statistically significant difference (P<0.05). The results for the remaining days showed similar WBS values (Table 1).
Table 1: Weight-bearing score of animals treated with linear and circular external fixators along with bone marrow aspirate and normal saline
Time |
Treatments Median (Range) |
||||
G1 |
G2 |
G3 |
G4 |
p-value |
|
Day-0 |
4 (3 - 4) |
4 (3 - 4) |
4 (3 - 4) |
4 (4 - 4) |
1.000 |
Day-7 |
3 (3 - 4) |
4 (3 - 4) |
2 (2 - 3) |
3 (2 - 3) |
0.009 |
Day-14 |
2 (2 - 3) |
3 (2 - 3) |
1 (1 - 2) |
2(1 - 2) |
0.002 |
Day-28 |
1 (1 - 2) |
2 (1 - 2) |
1 (0 - 1) |
1 (1 - 2) |
0.086 |
Day-45 |
0 (0 - 1) |
1 (0 - 1) |
0 (0 - 1) |
1 (1 - 2) |
0.066 |
G1: Animals treated with a linear external fixator and bone marrow aspirate; G2: Animals treated with a linear external fixator and normal saline; G3: Animals treated with a circular external fixator and bone marrow aspirate; G4: Animals treated with a linear external fixator and normal saline; differences were considered significant at P<0.05.
Radiographic scoring
The radiographic scoring results for the goats showed that there were improved RUS outcomes at days 7, 28, and 45 in animals treated with BMA compared to those treated with NS (P<0.05). The results for the remaining days showed similar RUS values (Table 2).
Table 2: Radiographic union score of animals treated with linear and circular external fixators along with bone marrow aspirate and normal saline
Time |
Treatments Median (Range) |
||||
G1 |
G2 |
G3 |
G4 |
p-value |
|
Day-0 |
0 (0 - 0) |
0 (0 - 0) |
0 (0 - 0) |
0 (0 - 0) |
--- |
Day-7 |
1 (0 - 0) |
0 (0 - 0) |
1 (0 - 0) |
0 (0 - 0) |
0.040 |
Day-14 |
2 (1 - 2) |
1 (1 - 2) |
2 (1 - 2) |
1 (1 - 1) |
0.040 |
Day-28 |
3 (2 - 3) |
2 (1 - 2) |
3 (2 - 3) |
2 (1 - 1) |
0.048 |
Day-45 |
4 (3 - 4) |
3 (2 - 4) |
4 (3 - 4) |
3 (3 - 4) |
0.143 |
G1: Animals treated with a linear external fixator and bone marrow aspirate; G2: Animals treated with a linear external fixator and normal saline; G3: Animals treated with a circular external fixator and bone marrow aspirate; G4: Animals treated with a linear external fixator and normal saline; differences were considered significant at P<0.05.
Blood parameters
There was no statistically significant difference in the sero-biochemical findings regarding phosphorus and calcium (p > 0.05). However, ALKP was significantly higher (P<0.05) in the BMA groups on days 7, 14, and 28 compared to the NS groups on days 14, 28, and 45 (P<0.05). FHP and THP were significantly higher (P<0.05) in the BMA groups on days 7, 14, 28, and 45 (Table 3).
Table 3: Sero-biochemical findings of animals treated with linear and circular external fixators along with bone marrow aspirate and normal saline
Parameter |
Days |
Treatments |
||||
G1 |
G2 |
G3 |
G4 |
p-value |
||
Phosphorus (mg/dl) |
0 |
6.01±1.63 |
6.61±1.083 |
6.50±1.77 |
7.38±2.20 |
0.662 |
7 |
6.00±1.82 |
8.02±1.24 |
6.34±1.60 |
5.56±1.95 |
0.149 |
|
14 |
6.52±1.04 |
7.88±1.14 |
6.96±0.98 |
6.82±1.79 |
0.402 |
|
28 |
5.88±1.14 |
7.50±1.01 |
6.28±1.36 |
6.72±1.50 |
0.255 |
|
45 |
5.75±1.17 |
6.62±0.88 |
7.36±3.17 |
7.50±1.40 |
0.459 |
|
Calcium (mg/dl)
|
0 |
8.40±1.140 |
8.80±1.30 |
8.40±0.89 |
8.80±1.30 |
0.899 |
7 |
10.00±0.70 |
10.00±1.00 |
10.60±1.14 |
10.20±1.30 |
0.786 |
|
14 |
11.60±1.51 |
11.40±0.54 |
10.80±1.30 |
11.20±0.83 |
0.710 |
|
28 |
11.80±1.09 |
12.60±0.54 |
11.20±0.83 |
12.20±0.83 |
0.111 |
|
45 |
9.60±1.14 |
9.20±0.83 |
9.40±0.89 |
9.60±1.14 |
0.909 |
|
ALKP (IU/L) |
0 |
88.58±11.60 |
119.72±34.93 |
86.74±10.13 |
99.96±39.82 |
0.250 |
7 |
176.11±30.43 |
161.29±31.34 |
227.36±43.45 |
138.85±51.15 |
0.019 |
|
14 |
288.26±51.66 |
221.44±36.15 |
317.09±44.92 |
212.71±53.98 |
0.007 |
|
28 |
310.16±63.06 |
212.49±35.09 |
371.64±52.13 |
272 51±64.38 |
0.003 |
|
45 |
304.81±59.48 |
273.15±72.54 |
350.70±44.61 |
273.52±55.50 |
0.166 |
|
FHP (mg/day)
|
0 |
8.42±0.03 |
8.16±0.17 |
8.49±0.02 |
8.46±0.02 |
0.001 |
7 |
10.62±0.42 |
9.72±0.42 |
10.08±0.55 |
9.67±0.44 |
0.019 |
|
14 |
11.78±0.97 |
11.02±0.23 |
11.30±0.37 |
10.86±0.06 |
0.073 |
|
28 |
12.39±0.32 |
11.18±0.33 |
12.23±0.61 |
11.18±0.33 |
0.001 |
|
45 |
13.45±0.34 |
12.56±0.32 |
13.60±0.40 |
12.48±0.50 |
0.001 |
|
THP (mg/day) |
0 |
10.42±0.04 |
10.29±0.27 |
10.46±0.05 |
10.46±0.03 |
0.240 |
7 |
11.62±0.42 |
10.51±0.53 |
11.05±0.56 |
10.42±0.02 |
0.002 |
|
14 |
12.70±0.46 |
11.67±0.48 |
12.38±0.77 |
11.41±0.13 |
0.004 |
|
28 |
14.23±0.38 |
12.48±0.43 |
14.27±0.72 |
12.69±0.75 |
0.001 |
|
45 |
15.19±0.42 |
13.63±0.45 |
14.27±0.72 |
12.69±0.75 |
0.001 |
G1: Animals treated with a linear external fixator and bone marrow aspirate; G2: Animals treated with a linear external fixator and normal saline; G3: Animals treated with a circular external fixator and bone marrow aspirate; G4: Animals treated with a linear external fixator and normal saline; differences were considered significant at P<0.05.
Discussion
Efforts are being made to develop new techniques for accurate diagnosis of complications of bone fractures and bone healing (18). Progressive improvement in weight-bearing was noticed for all the animals during the observation period. Weight-bearing was the same among the groups on day 0, while on days 7 and 14, there was a statistical difference among the groups. The results of the present analysis indicated that groups G1 and G3 showed better healing compared to groups G2 and G4. Due to the positive effect of BMA, which contains osteogenic cells and osteo-conductive factors that enhance the preparation of an inorganic scaffold and provide an easy regenerative system (19). This demonstrates the positive osteogenic properties of BMA (11).
The RUS showed improved outcomes on days 7, 28, and 45 in animals treated with BMA compared to those treated with NS. The results on the remaining days were similar regarding RUS. The results indicate that groups G1 and G3 showed better callus formation compared to groups G2 and G4. Similar results were noticed by (11), which are due to the positive effect of BMA on the radiographic characteristics of newly produced calluses at the fracture line. This positive effect is due to the delivery of connective tissue at concentrations higher than those naturally present in BM, which results in a great increase in the degree of bone combination capacity and machine-driven toughness of fractures (20).
No significance was observed regarding serum calcium among the groups. However, an increasing trend in serum calcium levels up to day 28 was observed. Increased levels of serum calcium in the initial stages are recognized to increase osteoclastic activity. Using bone plates for the reduction of bone fractures in goats and also observed a rise in serum calcium levels (21). Umarani and Ganesh observed a decrease in calcium level on the seventh day after the reduction of a femur fracture in goats, followed by a significant increase in concentration from day 15 to reach the normal level by day 60 of healing (22). The initial increasing trend of serum calcium levels is recognized to increase osteoclastic bone resorption during the initial stages of fracture healing and during the level of remodeling, which results in calcium mobilization into blood (23). There was an increasing trend in serum phosphorous levels. The elevation of serum phosphorous levels after the fixation of long bone fractures in goats (22). The increase in serum phosphorous is attributed to osteoclastic activity leading to the resorption of dead bone, thus increasing the levels of phosphorous (23).
Alkaline phosphatase had significantly higher values among the groups (G1, G2, G3, and G4), while FHP was observed to be higher in group G1 and group G3 compared to other groups, G2 and G4. Similar patterns were observed for THP. Scholar Manjulkar also observed similar biochemical changes during the healing of long bone fractures in goats, along with an increased level of serum ALKP (25). The rise in ALKP levels is due to increased osteoblastic activity as osteoblasts release a large quantity of ALKP that participates in the formation of bone matrix. Bone mineralization is also due to the property of BMA to induce osteoblastic proliferation and a rise in the activity of the alkaline phosphatase enzyme (26). Further studies have also mentioned an increased level of urinary excretion of FHP and THP following fractures compared to healthy individuals (27). This is because the definite phase of resorption lasts for 50 days due to the elevation of the residue as a result of continuing collagen synthesis (28).
Hydroxyproline is mainly present in collagen fibers and comprises almost 13% of an amino acid (29). It is derived from proline and is formed as a result of hydroxylation after translation that occurs in the peptide chain. Due to the degradation of collagen, FHP is released, which cannot be reutilized for the synthesis of collagen (30). Furthermore, about 50% of collagen exists in bone, where its turnover can be faster than that of soft tissues, which are eliminated in the urine. Therefore, it is considered a marker of bone resorption (31). Further studies have also observed increased levels of urinary FHP and THP following fractures compared to healthy animals (27). The measurement of sero-biochemical markers for bone healing during the process of fracture healing could augment the accuracy of the assessment of the bone healing stage (32). The results of this study are associated with the stimulation of osteoblasts, which play a vital role in the vigorous synthesis and maturation of the extracellular matrix of bone during the process of fracture healing (11).
Conclusion
In conclusion, the use of bone marrow aspirate shows promising osteogenic effects on the repair of metacarpal and metatarsal fractures in goats, especially when combined with external fixation.
Acknowledgment
I would like to express my gratitude to Dr. Hamad Akbar from the Department of Veterinary Surgery and Pet Sciences for his assistance in arranging the external fixators and guiding me throughout the study.
Conflict of interest
All authors have declared no conflicts of interest.